# reverSASP Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reversasp-therapeutics

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.reversasp.com
- Latest round: Seed (Jul 7, 2022)
- Investors on record: 2

## About

Based in Tokyo, Japan, and founded in 2022, reverSASP Therapeutics Co., Ltd., a.k.a. reverSASP Therapeutics is a bio-venture company that develops new drugs for aging-related diseases based on advanced science related to senescent cell research. In July 2022, reverSASP Therapeutics Co., Ltd. raised seed funding from Fast Track Initiative and UTokyo Innovation Platform.

The company develops a drug discovery pipeline for aging-related diseases by elucidating the properties of inflammatory senescent cells that are the root causes of numerous age-related diseases.

reverSASP Therapeutics plans to use its proceeds from July 2022 funding to promote future business operations.

## Funding rounds

- Seed, Jul 7, 2022 — Fast Track Initiative, UTokyo Innovation Platform

## Investors

- Fast Track Initiative (https://capitalatlas.ai/funds/fast-track-initiative) — Seed
- UTokyo Innovation Platform (https://capitalatlas.ai/funds/utokyo-innovation-platform) — Seed